Monday, January 9, 2017

Takeda to Buy Ariad for $4.7 Billion

Takeda Pharmaceutical has reached an agreement to buy once-battered Ariad Pharmaceuticals, maker of the leukemia treatment Iclusig, for about $4.7 billion in cash.

from WSJ.com: US Business http://ift.tt/2ivTFdS
via IFTTT

No comments:

Post a Comment